Revofil

Revofil is an innovative line of dermal fillers developed by the South Korean biotech company Caregen Co., Ltd., specializing in peptide technology. The products from the Revofil series are distinguished by their unique combination of cross-linked hyaluronic acid and bioactive peptides, resulting in a filler that not only restores volume but also actively contributes to skin tightening and improvement.

The Revofil formulas are designed to deliver natural and long-lasting results with a high degree of stability and safety. Thanks to the patented peptide technology, the breakdown of hyaluronic acid is slowed down, ensuring a durable effect with minimal swelling or migration.

The Revofil line is popular among aesthetic professionals worldwide due to its excellent injectability, natural results, and increased client comfort. The fillers are suitable for various indications such as wrinkle correction, contour enhancement, lip volume, and structural support.